GO:0004849 uridine kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004849 uridine kinase activity catalyzes the ATP-dependent phosphorylation of uridine to UMP, the first committed step of pyrimidine salvage.
• The reaction is ATP + uridine = ADP + UMP, and the enzyme also accepts cytidine, explaining the synonym uridine-cytidine kinase activity.
• UCKL1 (uridine-cytidine kinase like-1) is a catalytically active nucleoside kinase whose activity supports tumor growth.
• UCK2 and UCKL1 form a complex that exacerbates myocardial fibroblast differentiation after myocardial infarction via TRIM21/Smurf2/Smad3 signaling.
• Uridine kinase activity is elevated in human and rat tumors, making it a long-standing marker of proliferative pyrimidine demand.
• Developmental and hormonal signals, including thyroxine and 5-azacytidine, modulate uridine kinase activity in embryonic and neonatal tissues.
Description
Uridine kinase activity (GO:0004849) is a molecular_function term describing the catalysis of the reaction ATP + uridine = ADP + UMP. This phosphorylation event is the first committed step of the pyrimidine salvage pathway, converting the ribonucleoside uridine into uridine monophosphate (UMP) so that it can enter nucleotide pools for RNA synthesis and further pyrimidine interconversion. Because the reaction bypasses de novo pyrimidine biosynthesis, it is especially important in tissues and tumors that depend on salvaging preformed nucleosides. The term is also known by the synonyms uridine-cytidine kinase activity and uridine phosphokinase activity, reflecting the ability of the enzyme to phosphorylate cytidine as well as uridine. In humans, the best-characterized enzymes carrying this activity are uridine-cytidine kinase 2 (UCK2) and uridine-cytidine kinase like-1 (UCKL1), which can act alone or as a complex. Researchers study GO:0004849 to understand nucleotide homeostasis, nucleoside analog activation, and the metabolic rewiring that supports cancer cell proliferation. The activity is not static: it is modulated during development, by hormones such as thyroxine, and by nucleoside analogs such as 5-azacytidine. This article integrates the QuickGO definition with verified PubMed literature to summarize the mechanism, key genes, disease links, and experimental models relevant to uridine kinase activity.
uridine kinase activity At A Glance
| GO ID | GO:0004849 |
|---|---|
| GO term | uridine kinase activity |
| Ontology | molecular_function |
| Synonym | uridine-cytidine kinase activity; uridine phosphokinase activity |
| Definition | Catalysis of the reaction: ATP + uridine = ADP + UMP |
| Major function | Phosphorylates uridine (and cytidine) to UMP (and CMP), feeding the pyrimidine salvage pathway |
| Representative enzymes | UCK2, UCKL1 |
| Pathway context | Pyrimidine salvage; nucleotide homeostasis |
| Disease relevance | Cancer, myocardial infarction-associated fibrosis, developmental metabolic regulation |
What Is GO:0004849?
In simple terms, uridine kinase activity is the enzyme function that attaches a phosphate group from ATP onto uridine, producing UMP and ADP. According to the QuickGO definition, GO:0004849 describes catalysis of the reaction ATP + uridine = ADP + UMP. The activity belongs to the molecular_function ontology and is synonymous with uridine-cytidine kinase activity and uridine phosphokinase activity, because the same catalytic activity can also phosphorylate cytidine. It is a salvage-pathway activity that recycles preformed uridine rather than building pyrimidines from scratch.
Why Is uridine kinase activity Important in Cell Biology?
Uridine kinase activity matters because it controls the entry of preformed uridine into pyrimidine nucleotide pools, a flux that is essential for RNA synthesis and for the activation of many nucleoside-based drugs. In proliferating tumor cells, elevated uridine kinase activity supports the increased demand for pyrimidines and has been documented in both human and rat tumors. The activity is also implicated in non-cancer pathology: the UCK2/UCKL1 complex exacerbates myocardial fibroblast differentiation after myocardial infarction through TRIM21/Smurf2/Smad3 signaling. Because the reaction is chemically simple and genetically tractable, GO:0004849 provides a clean entry point for studying metabolic control of cell growth, differentiation, and drug response.
• Provides the first committed step of pyrimidine salvage, converting uridine to UMP.
• Supports RNA synthesis by maintaining UMP and downstream pyrimidine nucleotide pools.
• Activates nucleoside analog prodrugs, linking the activity to chemotherapy response.
• Is elevated in human and rat tumors, marking proliferative pyrimidine demand.
• Is modulated during embryonic and neonatal development, including in rat liver and cerebellum.
• Responds to hormonal signals such as thyroxine in the developing cerebellum.
• Is affected by nucleoside analogs such as 5-azacytidine, which modulates enzyme activity.
• Contributes to myocardial fibroblast differentiation via the UCK2/UCKL1 complex after myocardial infarction.
• Can be studied with isoform-resolved assays in neuroblastoma cell lines.
• Represents a druggable node in pyrimidine metabolism for cancer and fibrosis research.
Molecular Mechanism of uridine kinase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs uridine and ATP so they are positioned for phosphate transfer.
Uridine kinase activity accepts uridine as its primary substrate and also recognizes cytidine, which is why the term carries the synonym uridine-cytidine kinase activity. The enzyme binds the nucleoside and the phosphate donor ATP in a ternary arrangement that allows direct transfer of the gamma-phosphate to the 5'-hydroxyl of the ribose. Isoform-level studies in neuroblastoma cell lines have resolved two uridine-cytidine kinase isoforms with distinct purification and activity profiles, indicating that substrate handling can differ between enzyme variants.
Catalytic phosphate transfer
In simple terms: ATP donates a phosphate to uridine, making UMP and leaving ADP behind.
The catalytic event is the reaction ATP + uridine = ADP + UMP, exactly as defined for GO:0004849. This phosphorylation converts the neutral nucleoside into a charged monophosphate, trapping it inside the cell and committing it to nucleotide metabolism. The same catalytic activity can act on cytidine to produce CMP, consistent with the uridine-cytidine kinase synonym.
Product fate and pathway integration
In simple terms: The UMP produced is the starting material for all other pyrimidine nucleotides.
UMP generated by uridine kinase activity feeds into pyrimidine interconversion reactions that supply UDP, UTP, and CTP for RNA synthesis and glycosylation reactions. Because this step bypasses de novo synthesis, it is a key salvage route in cells with high nucleoside availability. Elevated uridine kinase activity in tumors is thought to reflect increased salvage flux supporting proliferation.
Isoform diversity and complex formation
In simple terms: Different enzyme versions and partnerships tune how much uridine kinase activity a cell has.
UCKL1 is a catalytically active nucleoside kinase whose activity contributes to tumor growth, establishing it as a functional carrier of uridine kinase activity alongside UCK2. UCK2 and UCKL1 can form a complex that exacerbates myocardial fibroblast differentiation after myocardial infarction via the TRIM21/Smurf2/Smad3 pathway, showing that the activity can be embedded in signaling-relevant protein assemblies. Two uridine-cytidine kinase isoforms have been purified and characterized in neuroblastoma cell lines, supporting the idea that isoform composition shapes total activity.
Developmental and hormonal modulation
In simple terms: The amount of uridine kinase activity changes with age and hormone exposure.
Uridine kinase activity in embryonic rat liver is modulated by 5-azacytidine, indicating that the activity is responsive to nucleoside analog exposure during development. Thyroxine affects uridine kinase activity in the developing rat cerebellum, linking the activity to hormonal control of brain maturation. These findings show that GO:0004849 is not a fixed housekeeping function but a regulated activity across developmental contexts.
Key Genes Involved in GO:0004849 uridine kinase activity
The following genes and proteins are directly associated with uridine kinase activity (GO:0004849) in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UCK2 | Uridine-cytidine kinase 2; carries uridine kinase activity and forms a complex with UCKL1 | Central enzyme for pyrimidine salvage and nucleoside analog activation |
| UCKL1 | Uridine-cytidine kinase like-1; catalytically active nucleoside kinase | Supports tumor growth; validated carrier of uridine kinase activity |
| UCK2/UCKL1 complex | Protein complex that exacerbates myocardial fibroblast differentiation | Links uridine kinase activity to TRIM21/Smurf2/Smad3 signaling after myocardial infarction |
| TRIM21 | E3 ubiquitin ligase in the UCK2/UCKL1 complex pathway | Component of the signaling axis downstream of the complex |
| Smurf2 | E3 ubiquitin ligase in the UCK2/UCKL1 complex pathway | Component of the signaling axis downstream of the complex |
| Smad3 | Transcription factor in the UCK2/UCKL1 complex pathway | Effector of fibroblast differentiation downstream of the complex |
| Uridine-cytidine kinase isoform 1 | One of two purified uridine-cytidine kinase isoforms | Isoform-resolved activity in neuroblastoma cell lines |
| Uridine-cytidine kinase isoform 2 | One of two purified uridine-cytidine kinase isoforms | Isoform-resolved activity in neuroblastoma cell lines |
| PKR | Double-stranded RNA-activated kinase affected by pseudouridine incorporation | Context for nucleoside modification and translation control |
| UGDH | UDP-glucose dehydrogenase involved in glycosaminoglycan synthesis | Lactylation-linked osteoarthritis biology relevant to nucleotide sugar metabolism |
| MAPK signaling components | Kinase cascade activated downstream of nucleocytoplasmic transport changes | Pathway context in osteoarthritis and fibrosis models |
| ATP | Phosphate donor for the uridine kinase reaction | Defines the reaction ATP + uridine = ADP + UMP |
| Uridine | Nucleoside substrate of the reaction | Primary substrate for GO:0004849 |
| Cytidine | Alternative nucleoside substrate | Explains the uridine-cytidine kinase synonym |
| UMP | Product of the reaction | First committed pyrimidine salvage intermediate |
| ADP | Product of the reaction | Byproduct of ATP-dependent phosphorylation |
| 5-azacytidine | Nucleoside analog that modulates uridine kinase activity | Used to perturb enzyme activity in embryonic rat liver |
| Thyroxine | Hormone that affects uridine kinase activity | Developmental regulator in rat cerebellum |
How Is uridine kinase activity Regulated?
Uridine kinase activity is regulated at multiple levels. During development, the activity in embryonic rat liver is modulated by 5-azacytidine, showing sensitivity to nucleoside analog exposure. In the developing rat cerebellum, thyroxine affects uridine kinase activity, indicating hormonal control of the salvage enzyme during brain maturation. Isoform composition provides another layer of regulation: two uridine-cytidine kinase isoforms with distinct purification and activity properties have been characterized in neuroblastoma cell lines. In disease contexts, the UCK2/UCKL1 complex integrates uridine kinase activity with TRIM21/Smurf2/Smad3 signaling to drive myocardial fibroblast differentiation after myocardial infarction. UCKL1 catalytic activity itself supports tumor growth, suggesting that the activity is tuned to proliferative demand. Together, these findings indicate that GO:0004849 is controlled by developmental, hormonal, isoform-specific, and disease-associated mechanisms.
uridine kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UCKL1 | Tumor growth supported by nucleoside kinase activity | UCKL1 knockout and overexpression cancer cell lines |
| UCK2/UCKL1 complex | Myocardial infarction-associated fibroblast differentiation | Cardiac fibroblast knockout and complex-disruption models |
| Uridine kinase (unspecified isoform) | Elevated activity in human and rat tumors | Tumor versus normal tissue enzyme activity assays |
| Uridine-cytidine kinase isoforms | Neuroblastoma cell line biology | Isoform-resolved purification and activity assays |
| Uridine kinase (developmental) | Embryonic liver and cerebellar development | 5-azacytidine and thyroxine perturbation models |
Uridine kinase activity in cancer
Increased uridine kinase activity has been documented in human and rat tumors, consistent with the elevated pyrimidine salvage demand of proliferating cells. UCKL1, a catalytically active nucleoside kinase carrying uridine kinase activity, supports tumor growth, making the activity a potential metabolic vulnerability. Because the enzyme also activates nucleoside analogs, its activity level can influence chemotherapy response. These observations position GO:0004849 as a cancer metabolism node linking salvage flux to tumor proliferation.
Uridine kinase activity in myocardial infarction and fibrosis
The UCK2/UCKL1 complex exacerbates the differentiation of myocardial fibroblasts via the TRIM21/Smurf2/Smad3 pathway after myocardial infarction. This places uridine kinase activity within a signaling network that promotes fibrotic remodeling in the heart. The finding expands the disease relevance of GO:0004849 beyond cancer into cardiovascular pathology.
Developmental and metabolic contexts
Uridine kinase activity in embryonic rat liver is modulated by 5-azacytidine, indicating a role in developmental nucleoside handling. Thyroxine affects the activity in the developing rat cerebellum, linking it to hormonal control of brain development. Related nucleotide sugar metabolism, such as UGDH lactylation in osteoarthritis, illustrates how pyrimidine-linked pathways can influence musculoskeletal disease. These contexts show that GO:0004849 participates in normal development as well as disease.
Nucleoside modification and translation control
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation, illustrating how nucleoside chemistry intersects with translation control. Although this finding concerns pseudouridine rather than uridine kinase activity directly, it provides context for how nucleoside metabolism and modification can shape gene expression. Such connections motivate studies that place GO:0004849 within broader nucleotide-dependent regulatory networks.
From uridine kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is UCKL1 catalytic activity required for tumor growth? | UCKL1 knockout and catalytically dead point-mutation cell lines |
| Does the UCK2/UCKL1 complex drive fibroblast differentiation? | Complex-disrupting knockout or knock-in models in cardiac fibroblasts |
| How do isoforms differ in uridine kinase activity? | Isoform-specific overexpression and purification in neuroblastoma cells |
| Does uridine kinase activity respond to nucleoside analogs? | 5-azacytidine treatment of embryonic liver models |
| Is uridine kinase activity hormonally regulated in brain development? | Thyroxine-treated developing cerebellum models |
| Can uridine kinase activity be measured in tumors? | Tumor versus normal tissue enzyme activity assays |
How to Study the uridine kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Uridine kinase activity assay | Conversion of uridine to UMP via ATP-dependent phosphorylation | Direct quantification of GO:0004849 in cells or lysates |
| Isoform purification | Separation and activity of uridine-cytidine kinase isoforms | Isoform-resolved enzymology in neuroblastoma cells |
| Expression profiling | Transcript or protein levels of UCK2 and UCKL1 | Linking gene expression to measured activity |
| Tumor versus normal comparison | Relative uridine kinase activity in malignant tissue | Cancer metabolism studies in human and rat tumors |
| Nucleoside analog treatment | Change in activity after 5-azacytidine exposure | Developmental modulation studies in embryonic liver |
| Hormone treatment | Change in activity after thyroxine exposure | Developmental neurobiology in rat cerebellum |
| Protein interaction analysis | Formation of the UCK2/UCKL1 complex | Fibrosis signaling studies after myocardial infarction |
| Growth assays with UCKL1 perturbation | Tumor cell proliferation upon loss of nucleoside kinase activity | Cancer target validation |
Enzyme activity assays
Direct measurement of uridine kinase activity uses the reaction ATP + uridine = ADP + UMP and has been applied to embryonic rat liver, tumors, and neuroblastoma cell lines. These assays quantify the conversion of uridine to UMP and can resolve isoform-specific contributions after purification. They remain the most direct way to test whether a genetic perturbation changes GO:0004849.
Isoform purification and characterization
Purification, activity, and expression-level analysis of two uridine-cytidine kinase isoforms in neuroblastoma cell lines provides a template for isoform-resolved study of GO:0004849. Such workflows separate enzyme variants before activity measurement, revealing whether total activity changes reflect one isoform or several. They are complementary to genetic approaches that remove or mutate a single gene.
Tumor and developmental perturbation models
Comparing human and rat tumors to normal tissue has been used to demonstrate increased uridine kinase activity in malignancy. Developmental models, including 5-azacytidine treatment of embryonic rat liver and thyroxine treatment of neonatal cerebellum, show how the activity responds to external cues. These systems are useful for testing whether a candidate regulator changes GO:0004849 in a physiological context.
Complex and pathway analysis
Studying the UCK2/UCKL1 complex requires methods that detect protein-protein interactions and downstream signaling through TRIM21, Smurf2, and Smad3. Combining complex disruption with readouts of fibroblast differentiation can establish whether uridine kinase activity is causally linked to the phenotype. Similar logic applies to UCKL1-dependent tumor growth, where catalytic activity and growth readouts are measured together.
How CRISPR Can Be Used to Study GO:0004849 uridine kinase activity
Knockout
CRISPR knockout of UCKL1 or UCK2 can test whether removing uridine kinase activity impairs tumor growth or fibroblast differentiation. Knockout models are especially useful when the goal is to eliminate all catalytic activity from a specific gene product. Combining knockout with direct enzyme assays confirms that the observed phenotype tracks with loss of GO:0004849.
Point Mutation
Catalytically dead point mutations in UCKL1 can separate kinase activity from scaffolding or interaction functions. Such mutants are valuable when a gene product participates in a complex, as with UCK2/UCKL1, because they preserve protein presence while removing catalysis. Point-mutation models therefore help attribute phenotypes specifically to uridine kinase activity.
Knock-in
Knock-in of tagged or reporter alleles at UCK2 or UCKL1 enables tracking of enzyme localization and abundance in disease models. Tagged knock-in lines can also support interaction studies that map the UCK2/UCKL1 complex and its downstream signaling. These models are useful when isoform-specific behavior must be preserved.
Overexpression
Overexpression of UCK2 or UCKL1 can elevate uridine kinase activity above baseline to test sufficiency in tumor growth or fibroblast differentiation. Overexpression systems are also convenient for producing enzyme for purification and isoform-resolved activity assays. When combined with nucleoside analog treatment, they can reveal how activity levels shape drug response.
How EDITGENE Supports uridine kinase activity Research
Researchers studying uridine kinase activity-related genes often need to determine whether a candidate gene is causally involved in a metabolic or disease phenotype, and CRISPR-based models provide a direct route to that answer. By combining knockout, point-mutation, knock-in, and overexpression strategies with functional readouts such as enzyme activity assays and growth or differentiation measurements, it becomes possible to link specific gene products to GO:0004849. EDITGENE supports this workflow with cell model engineering and screening services tailored to pyrimidine metabolism and nucleoside kinase biology.
Contact EDITGENE today to design your custom CRISPR model for uridine kinase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| UCK2 Knockout HEK293 Cell Line | EDJ-KQ5267 | Human | 7371 | Details Get a Quote |
| UCK1 Knockout HEK293 Cell Line | EDJ-KQ9859 | Human | 83549 | Details Get a Quote |
| UCKL1 Knockout HEK293 Cell Line | EDJ-KQ11999 | Human | 54963 | Details Get a Quote |
| UCK2 Knockout A-549 Cell Line | EDJ-KQ29590 | Human | 7371 | Details Get a Quote |
| UCK2 Knockout HCT 116 Cell Line | EDJ-KQ29592 | Human | 7371 | Details Get a Quote |
| UCK2 Knockout HeLa Cell Line | EDJ-KQ29593 | Human | 7371 | Details Get a Quote |
| UCK1 Knockout A-549 Cell Line | EDJ-KQ36725 | Human | 83549 | Details Get a Quote |
| UCK1 Knockout HCT 116 Cell Line | EDJ-KQ36726 | Human | 83549 | Details Get a Quote |
| UCK1 Knockout HeLa Cell Line | EDJ-KQ36727 | Human | 83549 | Details Get a Quote |
| UCKL1 Knockout HeLa Cell Line | EDJ-KQ39328 | Human | 54963 | Details Get a Quote |
| UCKL1 Knockout A-549 Cell Line | EDJ-KQ40576 | Human | 54963 | Details Get a Quote |
| UCKL1 Knockout HCT 116 Cell Line | EDJ-KQ40577 | Human | 54963 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About uridine kinase activity
What is uridine kinase activity?
Uridine kinase activity (GO:0004849) is the catalysis of the reaction ATP + uridine = ADP + UMP, the first committed step of pyrimidine salvage.
What is the GO ID for uridine kinase activity?
The GO ID is GO:0004849, a molecular_function term in the Gene Ontology.
What genes are involved in uridine kinase activity?
The main genes are UCK2 and UCKL1, which encode uridine-cytidine kinase 2 and uridine-cytidine kinase like-1.
What is the reaction catalyzed by uridine kinase?
The reaction is ATP + uridine = ADP + UMP, transferring a phosphate from ATP to uridine.
Why is uridine kinase activity important in cancer?
Increased uridine kinase activity has been found in human and rat tumors, and UCKL1 activity supports tumor growth.
How is uridine kinase activity regulated?
It is modulated by developmental signals, hormones such as thyroxine, nucleoside analogs such as 5-azacytidine, and isoform composition.
What are the synonyms of uridine kinase activity?
The synonyms are uridine-cytidine kinase activity and uridine phosphokinase activity.
Does uridine kinase activity accept cytidine?
Yes, the enzyme can also phosphorylate cytidine, which is why the term is synonymous with uridine-cytidine kinase activity.
How can I study uridine kinase activity in the lab?
Direct enzyme assays, isoform purification, expression profiling, and CRISPR perturbation models are commonly used.
Is uridine kinase activity linked to heart disease?
Yes, the UCK2/UCKL1 complex exacerbates myocardial fibroblast differentiation after myocardial infarction via TRIM21/Smurf2/Smad3 signaling.
Conclusion
Uridine kinase activity (GO:0004849) is a compact but consequential molecular function that converts uridine to UMP and feeds the pyrimidine salvage pathway. Its carriers, notably UCK2 and UCKL1, connect the activity to tumor growth, myocardial fibrosis, and developmental metabolic regulation. Because the reaction is simple and genetically tractable, it is well suited to CRISPR-based dissection of causality in disease models. Continued work on isoform-specific regulation and pathway integration will clarify how uridine kinase activity can be targeted in cancer and cardiovascular disease.
References
- 1. Matchett EC et al.. 2022. Characterization of uridine-cytidine kinase like-1 nucleoside kinase activity and its role in tumor growth.. Biochem J 479(11):1149-1164 PMID: 35583288
- 2. Lan W et al.. 2025. UGDH Lactylation Aggravates Osteoarthritis by Suppressing Glycosaminoglycan Synthesis and Orchestrating Nucleocytoplasmic Transport to Activate MAPK Signaling.. Adv Sci (Weinh) 12(20):e2413709 PMID: 40150862
- 3. Anderson BR et al.. 2010. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.. Nucleic Acids Res 38(17):5884-92 PMID: 20457754
- 4. Zhou X et al.. 2025. Uridine-Cytidine Kinase 2 (UCK2)/Uridine-Cytidine Kinase Like 1 (UCKL1) complex exacerbates the differentiation of myocardial fibroblasts via TRIM21/Smurf2/Smad3 pathway after myocardial infarction.. Mol Biomed 6(1):151 PMID: 41457201
- 5. Veselý J et al.. 1973. Uridine kinase in embryonic rat liver. Modulation of enzyme activity by 5-azacytidine.. Biochem J 133(4):609-13 PMID: 4127121
- 6. Shen F et al.. 1998. Increased uridine kinase (ATP: uridine 5'-phosphotransferase; EC 2.7.1.48) activity in human and rat tumors.. Cancer Biochem Biophys 16(1-2):1-15 PMID: 9923963
- 7. Meinsma R et al.. 2016. Purification, activity, and expression levels of two uridine-cytidine kinase isoforms in neuroblastoma cell lines.. Nucleosides Nucleotides Nucleic Acids 35(10-12):613-618 PMID: 27906629
- 8. Weichsel ME Jr. 1977. Thyroxine effect upon activity of uridine kinase in developing rat cerebellum.. Biol Neonate 31(3-4):199-207 PMID: 193585
